epirubicin

The drug is used to treat a wide range of neoplasms, including breast, stomach, liver, pancreatic, lung, ovarian, and rectal cancer, as well as malignant lymphomas, soft tissue sarcomas, leukemia, and superficial bladder cancer.

Form: concentrate for infusion solution

ATC: L01DB03

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used to treat a wide range of tumors, including breast, ovarian, stomach, lung, and colorectal cancer, as well as malignant lymphomas and leukemias. It is also used to treat superficial bladder cancer.

Form: solution for injection

ATC: L01DB03

Manufacturer: Actavis Italia S.p.A.

The drug is used to treat many types of cancer, including breast, ovarian, stomach, lung, liver, and pancreatic cancer, as well as rectal cancer, and for the treatment of malignant lymphomas, soft tissue sarcoma, and leukemia. When administered intravesically, it is effective against certain types of bladder cancer and for the prevention of its recurrence.

Form: solution for injection

ATC: L01DB03

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (secondary packaging, labeling, quality control and batch release)

The drug is used to treat a wide range of neoplasms, including breast, lung, stomach, liver, pancreatic, and rectal cancer, as well as ovarian cancer, and for the treatment of leukemia, malignant lymphomas, and soft tissue sarcomas. It is also used for the treatment of superficial bladder cancer.

Form: solution for injection

ATC: L01DB03

Manufacturer: Syndan-Pharma S.R.L.

The drug is used to treat a wide range of neoplasms, including breast cancer, lung cancer, stomach cancer, liver cancer, pancreatic cancer, rectal cancer, ovarian cancer, as well as malignant lymphomas, soft tissue sarcomas, and leukemia. It is also used for the treatment of superficial bladder cancer.

Form: solution for injection

ATC: L01DB03

Manufacturer: Maylan Laboratories Limited (OTL)